AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)

By AHRMM

On November 21, 2013, AHRMM submitted electronically

comments

to the Division of Dockets Management (HFA-305), Food and Drug Administration, Department of Health and Human Services, regarding the 

Draft Guidance for Industry

on the global unique device identification database (GUDID), which was issued on September 24, 2013.

 
In the comment letter, AHRMM supports all of the outlined attributes identified for the GUDID system; however, AHRMM’s comments pertain to three specific GUDID attributes that we strongly recommended be included in the GUDID database requirements In AHRMM’s November 6, 2012, response to the UDI proposed rule:

  • Labeled as hazardous: End-users should always be aware of devices that may pose hazards in order to ensure safe handling as well as product integrity.
  • Contains radioactive isotopes (e.g., radioactive element and atomic number) This information is important for environmentally-safe disposal and end-user handling.
  • Has Safety Data Sheet (SDS) This information provides end-users with a reliable and readily-available source of information should an urgent need arise.

These three attributes no longer appear in the Draft Guidance Document. AHRMM reiterates that the above attributes should be added to the database requirements. These attributes provide critical information that can be the difference between whether a device contributes to or detracts from quality patient care.

Related Resources

Toolkits/Methodology
Business Case for the UDI Presentation
With significant pressures on hospitals and healthcare systems, it is incumbent upon those who recognize the benefits of UDI to build the business
Guides/Reports
UDI Guidance Document for Medical Devices Containing HCT/P
Download Report
Guides/Reports
Business Case for the UDI Work Group Report
Overview: The Business Case for the UDI work group, a formal work group of the Association for Healthcare Resource & Materials Manage
Webcast
UDI: Value Beyond Compliance
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the val
Advisory
Announcement of GUDID Release 2.2 Deployment and Document Updates
An announcement of GUDID Release 2.2 deployment and document updates.
Webcast
Leading through Culture Change: Establishing New Values, Assumptions, and Norms
In this short webcast, Chris Wiekert, senior product manager at Infor, will take you through the steps he used to lead his department in a cu